New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Lantern Pharma Inc. (LTRN) vs Pulmatrix, Inc. (PULM)

Lantern Pharma Inc. and Pulmatrix, Inc. are both Biotechnology companies. Lantern Pharma Inc. and Pulmatrix, Inc. are of similar size ($4.9M and $4.9M). Across the 9 metrics below, Pulmatrix, Inc. leads on 7 and Lantern Pharma Inc. on 2.

Valuation

Metric LTRN PULM Biotechnology median
P/E n/m n/m 8.26
P/S n/m 0.66 9.20
P/B 2.68 14.24 2.09
Price to free cash flow n/m n/m 24.49
EV/EBITDA 0.22 n/m 0.67
EV/Sales n/m 0.94 9.05
Earnings yield (420.86%) (85.15%) (34.24%)
Free cash flow yield (339.75%) (79.15%) (24.77%)

Profitability

Metric LTRN PULM Biotechnology median
Gross margin 0.00% 100.00% 70.18%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (250.59%) (172.27%) (51.58%)
Return on assets (124.41%) (119.43%) (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LTRN PULM Biotechnology median
Revenue growth (TTM) — 6.96% 7.20%
EPS growth (last fiscal year) 18.65% 46.18% 29.04%
Revenue growth, 5-year CAGR — (0.26%) 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LTRN PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.49 2.32 4.83
Net debt to EBITDA 0.56 0.79 1.01

Dividend

Metric LTRN PULM Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric LTRN PULM Biotechnology median
Market cap 4.92m 4.89m 155.23m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack